DSG-Panel-Erbkrankheiten



Similar documents
TEST AND PRICE LIST FOR NEXT GENERATION SEQUENCING

Next-generation sequencing can replace Sanger sequencing in clinical diagnostics.

CLINICAL TEST PRICES BY DISEASE

Genetics and Cardiovascular diseases. Majid Alfadhel Geneticist and Pediatrician MD,MHSc,SSC Ped, ABHS(CH), FCCMG

9/17/2014. Conflict of Interest Disclosure. Support Foundation Fighting Blindness National Institutes of Health

Approaches to Integrating Next Generation Sequencing into the Electronic Health Record

1199 SEIU Benefit Funds Laboratory Management Program PRIOR AUTHORIZATION CODE LIST FOR OUTPATIENT MOLECULAR AND GENOMIC LABORATORY TESTS

2014 CPT Code Updates

MEDICAL POLICY Genetic Testing

Laboratory User Guides

LISTE DES ANALYSES HORS-QUEBEC List for testing done out of Québec LABORATOIRE CLINIQUES CUSM MUHC CLINICAL LABS

Doenças Raras de Demais Especialidades

Tabella 1: PrenatalScreen - Elenco dei geni analizzati e della malattie genetiche investigate

LISTE DES ANALYSES HORS-QUEBEC List for testing done out of Québec LABORATOIRE CLINIQUES CUSM MUHC CLINICAL LABS

CIC Edizioni Internazionali

Guidelines for Genetic Testing of Inherited Cardiac Disorders

JOHNS HOPKINS HEALTHCARE

Rare Mendelian Disorders Test Requisition Form

Cardio Gene panel experience. Jan Jongbloed Laboratory Specialist Clinical Genetics Genome Diagnostics Department of Genetics UMCG Groningen

LISTE DES ANALYSES HORS-QUEBEC List for testing done out of Québec LABORATOIRE CLINIQUES CUSM MUHC CLINICAL LABS

MEDICAL POLICY No R10 GENETICS: COUNSELING, TESTING, SCREENING

The Genetics of Hearing Loss. Heidi L. Rehm, Ph.D. Harvard Medical School Boston, MA

HEART GENE PANEL DG 2.3.x

ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing

GeneScreen : Elenco dei geni analizzati e malattie genetiche investigate

RMHP Prior Authorization List Effective October 1, 2015 rev 7/18/2016

Genetic Tests and Disease States Included in Humana s Genetic Guidance Program

Single Gene and NextGen Panels

Selection of non-synonymous variants in RP genes yielded an average of 84

Non-urgent Pre-service requests---within 3 business days of receipt of request. Urgent Pre-service requests---within 72 hours of receipt of request

Section: Genetic Testing Last Reviewed Date: October Policy No: 73 Effective Date: November 1, 2015

EPILEPSY. Childhood Epilepsy Epilepsy Associated Brain Malformation (EA-BMF40) Progressive Myoclonic Epilepsy

gyn.ox.ac.ukgyn.ox.ac.uk

Health First Health Plans Authorization List

Corporate Medical Policy

Molecular Pathology/Molecular Diagnostics/Genetic Testing

July 14, Centers for Medicare & Medicaid Services 7500 Security Boulevard Baltimore, MD 21244

Verzeichnis der seltenen Krankheiten und Synonyme

NEW YORK STATE MEDICAID PROGRAM LABORATORY PROCEDURE CODES

Test Information Sheet

HEREDITARY CANCER GENE PANEL DG 2.3.x

Oncomine Cancer Panel Patient Test Report

Maternal hyperglycemia and foetal epigenetic adaptations

Comprehensive List of Neuromuscular Disorders Covered by Muscular Dystrophy Canada

GENETIC TESTING AND MARFAN SYNDROME

MULTIPLE CONGENITAL ANOMALIES GENE PANEL

The Genomics of Hearing Loss

***Next Generation sequencing testing options available effective April 18 th, 2016***

ONE Paneli gene) A2m BPGM CSF1R FFAR4 HOXB6 LPAR6 NPC1L1 PTGDS SLC5A2 TRIM5 A4GALT BPI CSF2 FGA HOXD10 LPIN1 NPC2 PTGER2 SLC5A5 TRIO A4GNT

***Next Generation sequencing testing options available effective April 18 th, 2016***

MENDELIOME GENE PANEL DG 2.4.x

A Decision Support Tool to Facilitate Cancer Risk Assessment and Referral for Genetics Services. Kristen Vogel Postula, MS, CGC & Leigh Baumgart, PhD

rs CYP2C A>G G AA -/- rs CYP2C9 A6326C C AA -/-

MENDELIOME GENE PANEL DGD141114

DUKE EP SYMPOSIUM. Long QT Syndrome: Genotype- Phenotype Correlations

MULTIPLE CONGENITAL ANOMALIES GENE PANEL DGD

Highlights from the MedSeq Project: ClinGen Meeting

ONKOLOJİ ALANINDA KULLANILAN DNA TESTLERİ

Long QT. Long QT Syndrome. A Guide for

CPT Generic Test Test Description

La diagnostica molecolare nelle neoplasie colo-rettali. A do Scarpa. U iversita di Vero a

The Compassionate Allowances Initiative (CAL)

Nuovi Scenari in Oncologia. G. Zoppoli X-Files in Nutrizione Clinica e Artificiale, 08/06/2012

Prior Authorization Updates

Prevalenza delle mutazioni TMEM127 nel feocromocitoma sporadico

8 9 +

CPT Code Changes for 2015 PATHOLOGY/LABORATORY


EBiSC: The European Bank for induced pluripotent Stem Cells

Computer-based Personal Nutrition Guidance Martin Kohlmeier, MD, PhD

Pre-implantation genetic diagnosis: current status and future prospects

How To Write A Cancer Sequencing

Genomic instability in cancers and cancer predispositions. Popova Tatiana Inserm U830 Institut Curie

Objectives Role of Medical Genetics in Hearing Loss Evaluation. 5 y.o. boy with severe SNHL

Transcription:

DSG-Panel-Erbkrankheiten 153 Krankheiten 328 Gene Adrenoleukodystrophie (Addison-Schilder-Syndrom) Agammaglobulinämie Ahornsirupkrankheit (Leuzinose) Alagille-Syndrom Albinismus, Okulokutan Typ 1 Albinismus, Okulokutan Typ 2 Alopecia Universalis Congenita Alpers-Huttenlocher-Syndrom Alpha-Thalassämie Alport-Syndrom Alzheimer, früheinsetzend Amaurose, lebersche kongenital Amyotrophe Lateralsklerose Androgenresistenz Angioödem, hereditär Typ 1 und 2 Aniridie Aortendissektion Aortenstenose, angeboren Argininosuccinat-Lyase-Mangel Arylsulfatase-A-Mangel Ataxie mit okulomotorischer Apraxie Ataxie mit Vitamin-E-Mangel Ataxien, spinozerebellär Augen Albinismus Autoimmunerkrankungen, Polyendokrin Basalzellenkrebs (Basaliom, Basalzellkarzinom, Epithelioma basocellulare) Beta-Thalassämie Biotinidasemangel Blepharophimose Brachydaktylie Branchio-oto-renal Syndrom Brugada-Syndrom Ceroid-Lipofuszinose, neuronal PEX5, ABCD1 BTK BCKDHA, BCKDHB, DBT, DLD JAG1 TYR MC1R, OCA2 HR POLG HBA2 COL4A5 APP, PSEN1, PSEN2 AIPL1, CEP290, CRB1, GUCY2D, IMPDH1, RDH12, RPE65, RPGRIP1 SOD1 AKR1B1 SERPING1 PAX6 ACTA2, COL4A1, MYH11, SMAD3, TGFBR1, TGFBR2 ELN ASL ARSA APTX TTPA ATXN1, ATXN2, ATXN7 GPR143 AIRE PTCH1 HBB BTD FOXL2 GDF5, ROR2 EYA1, SIX1, SIX5 CACNA1C, CACNB2, GPD1L, HCN4, KCNE3, SCN1B, SCN3B, SCN5A PPT1

Charge-Syndrom Cherubismus Choroideremia Citrin-Mangel (Citrullinämie II) Coffin-Lowry-Syndrom Cornelia-de-Lange-Syndrom Cystinose Diamond-Blackfan-Syndrom Doppelkortex-Syndrom Duane-Syndrom Dysautonomie ( hereditäre sensible Neuropathie Typ III, Riley-Day-Syndrom), familiär Dysferlinopathie Dyskeratosis congenita (DC, DKC, Zinsser-Cole-Engman-Syndrom) Dystonie-Parkinson-Syndrom Ehlers-Danlos-Syndrom Einschlusskörpermyositis, sporadisch Emery-Dreifuss-Muskeldystrophie (EDMD) Epidermolysis bullosa simplex Erythromelalgie Exostose/ Multiple kartilaginäre Exostosen Fallot-Tetralogie Fanconi-Anämie (FA) Friedreich-Ataxie (Morbus Friedreich) Galaktosämie, angeborene Stoffwechselstörung Gliedergürteldystrophie Glycin-Enzephalopathie Glykogenspeicherkrankheiten (Glykogenosen) Hämochromatose, erblich Hemophilie A Hemophilie B Hexosaminidasen (Tay-Sachs-Syndrom) HIBC-Mangel (3-Hydroxyisobutyryl-CoA- Hydrolase-Mangel) Holt-Oram-Syndrom Hyperthermie, maligne Hypertrophe Kardiomyopathie, familiär Hypochondroplasie (HCH) Hypophosphatasie Immunschwächekrankheit SCID CHD7 SH3BP2 CHM SLC25A13 RPS6KA3 NIPBL CTNS RPL11, RPL35A, RPS10, RPS19, RPS24, RPS26 DCX SALL4 IKBKAP DYSF DKC1 TAF1 COL3A1, COL5A1, COL5A2, TNXB, PLOD1 GNE EMD COL7A1, ITGB4, KRT14, KRT5, LAMB3, PLEC SCN9A EXT1 NKX2-5 FANCA, FANCC, FANCF, FANCG FXN GALT LMNA, CAPN3 AMT, GCSH, GLDC GBE1 HFE F8 F9 HEXA HIBCH TBX5 RYR1 ACTC1, CALR3, CAV3, MYBPC3, MYH6, MYH7, MYL2, MYL3, MYLK, MYOZ2, PRKAG2, RPS7, SLC25A4, TNNT2, TPM1, VCL FGFR3 ALPL IL2RG

Kampomele Dysplasie Kardiomyopathie, arrhythmogene rechtsventrikuläre Kardiomyopathie, dilatative Kartagener-Syndrom und Primäre ciliäre Dyskinesie Kongenitale Störung der Gykosylierung Typ 1A (CDG-1A) Kongenitales Katarakt-faziale Dysmorphien- Neuropathie-Syndrom (CCFDN-Syndrom) Kraniosynostose Li-Fraumeni-Syndrom Lissenzephalie (Miller-Dieker-Syndrom) Long QT-Syndrom Long/Short-QT-Syndrom Louis-Bar-Syndrom Lowe-Syndrom (okulo-zerebro-renales Syndrom) Lujan-Fryns-Syndrom Marfan-Syndrom Menkes-Syndrom Methylmalonazidurie (MMA) Morbus Canavan Morbus Charcot-Marie-Tooth (Typ 1 und 2) Morbus Darier Morbus Fabry ( Fabry-Krankheit, Fabry-Syndrom, Fabry-Anderson-Krankheit) Morbus Gaucher (Gaucher-Syndrom) Morbus Hunter (Mukopolysaccharidose Typ II) Morbus Hunter/Scheie (Hurler Syndrom) Morbus Osler (erblich hämorrhagischen Teleangiektasien) Morbus Pompe (Pompe sche Krankheit) Morbus Wilson Mukolipidosen (ML) Mukoviszidose Multiple endokrine Neoplasie Muskeldystrophie Becker-Kiener Muskeldystrophie, fazioskapulohumeral (Landouzy-Déjérine-Syndrom) Muskeldystrophien (progressive Muskeldystrophie) SOX9 DSC2, DSG2, DSP, JUP, PKP2, RYR2, TMEM43 DES, LAMP2, LDB3, SGCD, STARD3, TAZ, TNNC1, TNNI3, ACTN2, BAG3, ABCC9, PLN CCDC39, CCDC40, DNAH11, DNAH5, DNAH9, DNAI1, DNAI2, RSPH4A, RSPH9, TXNDC3 PMM2 CTDP1 FGFR1 CHEK2, TP53 PAFAH1B1 AKAP9, KCNE1, KCNE2, KCNH2, KCNQ1, SCN4B, SNTA1 ANK2 ATM OCRL MED12 FBN1 ATP7A MMAA, MMAB, MMACHC, MUT ASPA DNM2, PMP22, MPZ, MFN2 ATP2A2 GLA GBA IDS IDUA ENG GAA ATP7B GNPTAB CFTR MEN1, RET DMD FRG1 PABPN1

Myasthenie-Syndrom, kongenital CHAT, CHRNA1, CHRNB1, CHRND, CHRNE, DOK7, RAPSN Myotonia congenita Thomsen CLCN1 Myotubuläre Myopathie MTM1 Nemalin-Myopathie TNNT1 Nephroblastom (Wilms-Tumor) GPC3, WT1 Neurofibromatose Typ 1 (Morbus Recklinghausen) NF1 Neurofibromatose Typ II (zentrale NF2 Neurofibromatose) Niemann-Pick-Krankheit (Morbus Niemann Pick, NPC1, NPC2 Niemann-Pick-Syndrom, Sphingomyelinlipidose) Noonan-Syndrom KRAS, NRAS, PTPN11, RAF1, SOS1 Nystagmus FRMD7 Ornithintranscarbamylase-Mangel OTC Osteogenesis Imperfecta (Glasknochenkrankheit) COL1A1, COL1A2 Parkinson (Morbus Parkinson) FBXO7, LRRK2, PINK1, SNCA Parkinson-Dementia-Syndrom MAPT Pendred Syndrome SLC26A4 Phenylketonurie (PKU) PAH Polyposis, familiär adenomatöse TTR, APC Polyposis-Syndrom, juvenilen BMPR1A, SMAD4 Porphobilinogen-Deaminase (Hydroxymethylbilan- HMBS Synthase) ABCA4, ARL6, CA4, CERKL, CNGB1, CRX, EYS, FSCN2, KLHL7, LRAT, MAPRE2, MERTK, NR2E3, Retinitis pigmentosa (Netzhauterkrankung) NUDT19, PRCD, PROM1, PRPF31, PRPF8, PRPH2, RHO, RP9, RPGR, SEMA4A, SNRNP200, SPATA7, TOPORS, TULP1, BEST1, RB1 Retinoschisis RS1 Rett-Syndrom MECP2 Saethre-Chotzen Syndrom TWIST1 SCID, schwerer kombinierter Immundefekt ADA, RAG1, RAG2 Short-QT-Syndrom KCNJ2 Sklerose, tuberös TSC1, TSC2 Smith-Lemli-Opitz Syndrom DHCR7 Smith-Magenis-Syndrom (SMS) RAI1 Sotos-Syndrom NSD1 Spastische Paraplegie 7, hereditär SPG7, KIAA0196, L1CAM, ATL1 Stickler-Syndrom COL9A1, COL11A1, COL2A1 Tachykardie, ventrikulär CASQ2 Taubheit, erblich COL11A2, KCNQ4, GJB2, GJB3, GJB6 Treacher-Collins-Syndrom TCOF1 Trimethylaminurie (Fish-Odor-Syndrom) FMO3

Turcot-Syndrom Usher-Syndrom VLCADD Von-Hippel-Lindau Syndrom (Morbus Hippel- Lindau) Vorhofseptumdefekt Waardenburg-Syndrom Werner-Syndrom Wiskott-Aldrich-Syndrom Zellweger-Syndrom Zerebrotendinöse Xanthomatose Zystennieren (polyzystische Nieren) α1-antitrypsin-mangel MLH1, MSH2 CDH23, MYO7A, PCDH15, USH1C, USH2A ACADVL VHL GATA4 PAX3 WRN WAS PEX1, PEX3, PEX10, PEX13, PEX14, PEX19, PEX26 CYP27A1 PKD1, PKD2, PKHD1 SERPINA1